HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection

The incidence of oropharyngeal cancer (OPC) related to infection with human papillomavirus (HPV) is rising, making it now the most common HPV-related malignancy in the United States. These tumors present differently than traditional mucosal head and neck cancers, and those affected often lack classi...

Full description

Bibliographic Details
Main Authors: Mary Roz Timbang, Michael W. Sim, Arnaud F. Bewley, D. Gregory Farwell, Avinash Mantravadi, Michael G. Moore
Format: Article
Language:English
Published: Taylor & Francis Group 2019-08-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2019.1600985
_version_ 1827767363047522304
author Mary Roz Timbang
Michael W. Sim
Arnaud F. Bewley
D. Gregory Farwell
Avinash Mantravadi
Michael G. Moore
author_facet Mary Roz Timbang
Michael W. Sim
Arnaud F. Bewley
D. Gregory Farwell
Avinash Mantravadi
Michael G. Moore
author_sort Mary Roz Timbang
collection DOAJ
description The incidence of oropharyngeal cancer (OPC) related to infection with human papillomavirus (HPV) is rising, making it now the most common HPV-related malignancy in the United States. These tumors present differently than traditional mucosal head and neck cancers, and those affected often lack classic risk factors such as tobacco and alcohol use. Currently, there are no approved approaches for prevention and early detection of disease, thus leading many patients to present with advanced cancers requiring intense surgical or nonsurgical therapies resulting in significant side effects and cost to the health-care system. In this review, we outline the evolving epidemiology of HPV-related OPC. We also summarize the available evidence corresponding to HPV-related OPC prevention, including efficacy and safety of the HPV vaccine in preventing oral HPV infections. Finally, we describe emerging techniques for identifying and screening those who may be at high risk for developing these tumors.
first_indexed 2024-03-11T11:57:42Z
format Article
id doaj.art-525c207cfb844dabb49d1c68418730f7
institution Directory Open Access Journal
issn 2164-5515
2164-554X
language English
last_indexed 2024-03-11T11:57:42Z
publishDate 2019-08-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj.art-525c207cfb844dabb49d1c68418730f72023-11-08T11:55:19ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2019-08-01157-81920192810.1080/21645515.2019.16009851600985HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detectionMary Roz Timbang0Michael W. Sim1Arnaud F. Bewley2D. Gregory Farwell3Avinash Mantravadi4Michael G. Moore5The University of California, DavisIndiana UniversityThe University of California, DavisThe University of California, DavisIndiana UniversityIndiana UniversityThe incidence of oropharyngeal cancer (OPC) related to infection with human papillomavirus (HPV) is rising, making it now the most common HPV-related malignancy in the United States. These tumors present differently than traditional mucosal head and neck cancers, and those affected often lack classic risk factors such as tobacco and alcohol use. Currently, there are no approved approaches for prevention and early detection of disease, thus leading many patients to present with advanced cancers requiring intense surgical or nonsurgical therapies resulting in significant side effects and cost to the health-care system. In this review, we outline the evolving epidemiology of HPV-related OPC. We also summarize the available evidence corresponding to HPV-related OPC prevention, including efficacy and safety of the HPV vaccine in preventing oral HPV infections. Finally, we describe emerging techniques for identifying and screening those who may be at high risk for developing these tumors.http://dx.doi.org/10.1080/21645515.2019.1600985oropharyngeal cancerhpvvaccinationdetectionscreeningprevention
spellingShingle Mary Roz Timbang
Michael W. Sim
Arnaud F. Bewley
D. Gregory Farwell
Avinash Mantravadi
Michael G. Moore
HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection
Human Vaccines & Immunotherapeutics
oropharyngeal cancer
hpv
vaccination
detection
screening
prevention
title HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection
title_full HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection
title_fullStr HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection
title_full_unstemmed HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection
title_short HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection
title_sort hpv related oropharyngeal cancer a review on burden of the disease and opportunities for prevention and early detection
topic oropharyngeal cancer
hpv
vaccination
detection
screening
prevention
url http://dx.doi.org/10.1080/21645515.2019.1600985
work_keys_str_mv AT maryroztimbang hpvrelatedoropharyngealcancerareviewonburdenofthediseaseandopportunitiesforpreventionandearlydetection
AT michaelwsim hpvrelatedoropharyngealcancerareviewonburdenofthediseaseandopportunitiesforpreventionandearlydetection
AT arnaudfbewley hpvrelatedoropharyngealcancerareviewonburdenofthediseaseandopportunitiesforpreventionandearlydetection
AT dgregoryfarwell hpvrelatedoropharyngealcancerareviewonburdenofthediseaseandopportunitiesforpreventionandearlydetection
AT avinashmantravadi hpvrelatedoropharyngealcancerareviewonburdenofthediseaseandopportunitiesforpreventionandearlydetection
AT michaelgmoore hpvrelatedoropharyngealcancerareviewonburdenofthediseaseandopportunitiesforpreventionandearlydetection